Drug study with Efgartigimod for POTS

[GasDoc]

Interesting study being planned for POTS with Efgartigimod. A monoclonal antibody fragment that binds other antibodies. Think of it like a pharmaceutical immunoadsorption without the extracorporeal circuit.

More info on the drug here ⬇️

Efgartigimod

www.argenx.com

More info on the study here ⬇️

https://twitter.com/i/web/status/1598343648416075777

Essentially demonstrates that at least one pharmaceutical company believes that POTS is autoimmune, with autoantibodies in nature.

 

[Cort]

Nice! Thanks for that. Also used in myasthenia gravis interestingly given the Mestinon connection

 

[SarahTee]

Interesting study being planned for POTS with Efgartigimod. A monoclonal antibody fragment that binds other antibodies. Think of it like a pharmaceutical immunoadsorption without the extracorporeal circuit.

More info on the drug here ⬇️

Efgartigimod

www.argenx.com

More info on the study here ⬇️

https://twitter.com/i/web/status/1598343648416075777

Essentially demonstrates that at least one pharmaceutical company believes that POTS is autoimmune, with autoantibodies in nature.

Interesting study being planned for POTS with Efgartigimod. A monoclonal antibody fragment that binds other antibodies. Think of it like a pharmaceutical immunoadsorption without the extracorporeal circuit.

More info on the drug here ⬇️

Efgartigimod

www.argenx.com

More info on the study here ⬇️

https://twitter.com/i/web/status/1598343648416075777

Essentially demonstrates that at least one pharmaceutical company believes that POTS is autoimmune, with autoantibodies in nature.

Is it this one?

Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS - Full Text View - ClinicalTrials.gov

Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS - Full Text View.

clinicaltrials.gov

I couldn’t see the Twitter link (my computer is ancient). Sorry to bother you.

 

[GasDoc]

Is it this one?

Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS - Full Text View - ClinicalTrials.gov

Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS - Full Text View.

clinicaltrials.gov

I couldn’t see the Twitter link (my computer is ancient). Sorry to bother you.

Yep 👍 that’s the one. Sorry for the delay in getting back to you.

 

[SarahTee]

Thank you, @GasDoc, very interesting.